Biography

Dr. Feng Li is an Associate Professor at the Department of cell biology and Neurobiology, Xuzhou Medical University. She received her PhD at Shandong Agricultural University in 2010. She completed her postdoctoral training at Nanjing Medical University in the pathogenesis of glioma.

Her research focuses on the pathogenesis of tumor, with particular emphasis on the biomarker and the molecular mechanism of glioma. She has published over 20 SCI-indexed papers, with more than 100 citations.

Education

Shandong Agricultural University, 09/2005 – 07/2010, PhD        

Shandong Agricultural University, 09/2001 – 07/2005, Bachelor of Science

Publications:

1．JY Liu, Xu Cao, YL Lu, MM Hu, YT Dou, SL Luo , K Ji, QY Pei, KX Zeng, YG Zheng, J Cao, QY Wu*, F Li*. CAPN1 Promotes the Progression of MLL-Rearranged Acute Myeloid Leukemia by Suppressing SHP-1 and Activating MAPK/ERK Signaling Pathway. BBA - Molecular Basis of Disease, 2026, Accepted.

2．Li F^#, Lu ZY, Xue YT, Liu Y, Cao J, Sun ZT, Zhang Q, Xu MD, Wang XY*, Xu KL*, Wu QY *. Molecular basis of JAK2 H608Y and H608N mutations in the pathology of acute myeloid leukemia. Int J Biol Macromol. 2023, 229:247-259.

3．Zhang S, Liu J, Lu ZY, Xue YT, Mu XR, Liu Y, Cao J, Li ZY, Li F*, Xu KL*, Wu QY*. Combination of RSK inhibitor LJH-685 and FLT3 inhibitor FF-10101 promoted apoptosis and proliferation inhibition of AML cell lines. Cell Oncol (Dordr). 2022, 45(5): 1005-1018.

4．Mu XR, Ma MM, Lu ZY, Liu J, Xue YT, Cao J, Zeng LY, Li F*, Xu KL*, Wu QY *. Effects of the PLK4 inhibitor Centrinone on the biological behaviors of acute myeloid leukemia cell lines. Front Genet. 2022, 13:898474.

5．Zhang CC, Wu T, Guan L, Wang YJ, Yao RQ, Gao DS, Li F *. Effects of STAT3 Inhibitor BP-1-102 on The Proliferation, Invasiveness, Apoptosis and Neurosphere Formation of Glioma Cells in Vitro. Cell Biochem Biophys. 2022, 80(4): 723-735.